Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Read more about Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Read more about Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai Read more about Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers Read more about A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System Read more about The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
Safety and Efficacy of PC945 in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis Read more about Safety and Efficacy of PC945 in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer Read more about A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma Read more about Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma
Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC) Read more about Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)
Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens Read more about Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens